Rossen R M, Alderman E L, Harrison D C
Br Heart J. 1976 Jul;38(7):695-700. doi: 10.1136/hrt.38.7.695.
Vasodilator therapy has been shown to have beneficial effects in heart failure. In order to evaluate the haemodynamic actions of vasodilator administration in primary congestive cardiomyopathy, sodium nitroprusside was infused intravenously at a rate of 15 to 100 mug/min to 12 patients. Mean arterial pressure fell 15 per cent from 86+/-3-0 to 72+/-2-4 mmHg (11-40 +/- -4 to 9-6 +/- 0-3 kPa), and there was a small but significant decrease in mean heart rate from 96 +/- 4-8 to 90 +/- 4-4 beats/min. These changes were accompanied by a significant decrease in mean pulmonary artery pressure from 40 +/- 2-2 to 26 +/- 2-8 mmHg (5-3 +/- 0-3 kPa to 3-5 +/- 0-4 kPa), mean pulmonary capillary wedge pressure from 25 +/ -2-2 to 16 +/- 2-1 mmHg (3-3 +/- 0-3 to 2-1 +/- 0-3 kPa), and left ventricular end-diastolic pressure from 27 +/- 1-8 to 17 +/- 1-5 mmHg (3-6 +/- 0-3 to 2-3 +/- 0-2 kPa). Cardiac index increased by an average of 48 per cent from 2-1 to 3-1 l/min per m2, and left ventricular stroke work index increased from 18-4 +/- 1-6 to 21-3 +/- 1-9 g m/m2. These results show that pronounced left ventricular dysfunction in patients with congestive cardiomyopathy is improved during vasodilator therapy.
血管扩张剂疗法已被证明对心力衰竭有有益作用。为了评估血管扩张剂在原发性充血性心肌病中的血流动力学作用,对12例患者以15至100微克/分钟的速率静脉输注硝普钠。平均动脉压从86±3.0降至72±2.4 mmHg(11.40±0.4至9.6±0.3 kPa),下降了15%,平均心率略有但显著下降,从96±4.8降至90±4.4次/分钟。这些变化伴随着平均肺动脉压从40±2.2降至26±2.8 mmHg(5.3±0.3至3.5±0.4 kPa)、平均肺毛细血管楔压从25±2.2降至16±2.1 mmHg(3.3±0.3至2.1±0.3 kPa)以及左心室舒张末期压力从27±1.8降至17±1.5 mmHg(3.6±0.3至2.3±0.2 kPa)的显著下降。心脏指数平均从2.1增加到3.1升/分钟每平方米,增加了48%,左心室每搏功指数从18.4±1.6增加到21.3±1.9克米/平方米。这些结果表明,充血性心肌病患者明显的左心室功能障碍在血管扩张剂治疗期间得到改善。